Risa Michelle Wolf, M.D.

Headshot of Risa Michelle Wolf
  • Director, Pediatric Diabetes Program
  • Associate Professor of Pediatrics


Diabetes, Endocrinology, Pediatric Endocrinology

Request an Appointment

Insurance Information

Main Phone

Outside of Maryland & Washington D.C.

Request Appointment

International Patients

Request Appointment


Johns Hopkins Pediatrics

Appointment Phone: 443-997-5437
200 N. Wolfe Street
Rubenstein Child Health Building
Baltimore, MD 21287 map
Phone: 410-955-6463 | Fax: 410-955-9773


Dr. Risa Wolf is an Associate Professor of Pediatrics in the Division of Pediatric Endocrinology at the Johns Hopkins University School of Medicine. Her clinical practice focuses on pediatric diabetes care and other endocrine issues. 

Dr. Wolf received her undergraduate degree from the University of Pennsylvania, after which she attended the Mount Sinai School of Medicine where she graduated with Distinction in Research, and was inducted into the Alpha Omega Alpha Honor Medical Society. She completed her pediatric residency at the Children's Hospital of Philadelphia, followed by a fellowship in pediatric endocrinology at the Johns Hopkins Hospital. During her fellowship, Dr. Wolf was awarded prestigious grants from both the Pediatric Endocrine Society and the Endocrine Society to support her research in obesity and metabolism. Dr. Wolf also spent two years working at Broward Health in Florida, where she developed a Comprehensive Pediatric Diabetes Center. She is the Founder and Medical Director of Camp Charm City diabetes camp in Baltimore, MD. 

Dr. Wolf's research focus is on clinical care innovations to improve outcomes in pediatric diabetes. She is the Principal Investigator of a study implementing point-of-care diabetes retinopathy screening into pediatric diabetes care, a Co-Investigator for Trialnet, and the Principal Investigator for the Pediatric Diabetes Consortium site at Johns Hopkins. She also studies a novel family of proteins, called CTRPs, to determine their impact on glucose and lipid metabolism in the context of obesity and diabetes. 

Dr. Wolf is affiliated with the American Academy of Pediatrics, the Pediatric Endocrine Society, the Endocrine Society, and the American Diabetes Association.

...read more


  • Director, Pediatric Diabetes Program
  • Associate Professor of Pediatrics

Departments / Divisions



  • MD; Icahn School of Medicine at Mount Sinai (2008)


  • Pediatrics; Children's Hospital of Philadelphia (2011)


  • Pediatric Endocrinology; Johns Hopkins University School of Medicine (2015)

Board Certifications

  • American Board of Pediatrics (Pediatric Endocrinology) (2015)
  • American Board of Pediatrics (Pediatrics) (2011)

Research & Publications

Research Summary

Dr. Wolf's research is focused on clinical care innovations in pediatric diabetes. She is the principal investigator of several studies utilizing innovative technologies to improve glycemic control and outcomes in youth with diabetes.  She also studies a novel family of proteins, called CTRPs, to determine their impact on glucose and lipid metabolism in the context of obesity and diabetes.

Videos & Media

Recent News Articles and Media Coverage

When Distance Is a Barrier to Specialized Care, BroadcastMed (May 2, 2019)

9/2019 Children with Diabetes Find a Camp They Can Count on at Camp Charm City Diabetes, Johns Hopkins Medicine (August 30, 2019)

Endocrine today; Black and Hispanic children underrepresented at diabetes summer camps, Healio (January 28, 2020)

Adult-Proven ‘Smart’ Diagnostic Tool for Diabetic Retinopathy Also Works for Kids, Johns Hopkins Medicine (February 2, 2021)

Breaking Down Diabetes, What Johns Hopkins Experts Want You to Know, Facebook Live (January 22, 2021

A Fuzzy Fix: How ‘Social Toys’ Can Help Kids Battle Illness and Anxiety, USNews (February 8, 2021)

The Pandemic Seems to have made childhood obesity worse, but there’s hope. New York Times (June 2021)

Minority Youth Less Likely to Undergo Diabetic Eye exams, Review of Optometry (June 7, 2021)

Study Suggests Youth Who Use Insulin Pumps Less at Risk for Diabetic Retinopathy; Hopkins Medicine Newsroom (October 07, 2021)

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Is this you? Edit Profile
back to top button